Upgrade to SI Premium - Free Trial

JPMorgan Upgrades Novavax (NVAX) to Overweight

September 21, 2018 5:39 AM
JPMorgan analyst Eric Joseph upgraded Novavax (NASDAQ: NVAX) from Underweight to Overweight.The analyst double upgrades ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles